High-grade prostatic intraepithelial neoplasia (HGPIN) in retropubic radical prostatectomy specimens predicts a significantly higher risk of biochemical recurrence of prostate cancer, according to a study published in BJU International (2007;100:1066-1070).
The biochemical failure risk was nearly twofold greater in the 1,885 men with HGPIN than in the 248 men without HGPIN, after controlling for PSA level, pathological stage, and Gleason sum.
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Please login or register first to view this content.